ArticleGut and liver2026

Second-Line and Subsequent Therapies after Atezolizumab Plus Bevacizumab Treatment in Hepatocellular Carcinoma: A Multicenter Prospective Cohort Study.

Yuri Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.